We are live on ! Find out more
CBT

Central Bank & Trust Portfolio holdings

AUM $705M
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
-12.55%
1 Year Est. Return
+34.21%
3 Year Est. Return
+110%
5 Year Est. Return
+142.3%
10 Year Est. Return
+478.86%
AUM
$396M
AUM Growth
-$36M
Cap. Flow
+$28.1M
Cap. Flow %
7.09%
Top 10 Hldgs %
34.72%
Holding
283
New
19
Increased
49
Reduced
102
Closed
16

Top Buys

Rank Stock Value
1
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$16.3M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$5.81M
3
HPQ icon
HP
HPQ
+$4.79M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.8M
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.77M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$4.47M
2
MAS icon
Masco
MAS
+$4.05M
3
AET
Aetna Inc
AET
+$2.43M
4
AMAT icon
Applied Materials
AMAT
+$1.54M
5
MU icon
Micron Technology
MU
+$1.43M

Sector Composition

Rank Sector Weight
1 Technology 10.86%
2 Healthcare 10.86%
3 Financials 10.43%
4 Consumer Discretionary 7%
5 Consumer Staples 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
251
GSK
GSK
$107B
$4K ﹤0.01%
80
– –
IP icon
252
International Paper
IP
$22.6B
$4K ﹤0.01%
95
-64
-40% -$2.69K
JCI icon
253
Johnson Controls International
JCI
$85.1B
$4K ﹤0.01%
128
– –
MTB icon
254
M&T Bank
MTB
$36.3B
$4K ﹤0.01%
30
-30
-50% -$4.8K
VRTX icon
255
Vertex Pharmaceuticals
VRTX
$123B
$4K ﹤0.01%
24
– –
AGN
256
DELISTED
Allergan plc
AGN
$4K ﹤0.01%
27
– –
BF.B icon
257
Brown-Forman Class B
BF.B
$13.5B
$3K ﹤0.01%
59
-300
-84% -$14.3K
BOE icon
258
BlackRock Enhanced Global Dividend Trust
BOE
$659M
$3K ﹤0.01%
300
– –
BSX icon
259
Boston Scientific
BSX
$68.4B
$3K ﹤0.01%
91
– –
HBI
260
DELISTED
Hanesbrands
HBI
$3K ﹤0.01%
200
– –
NVCR icon
261
NovoCure
NVCR
$1.77B
$3K ﹤0.01%
+100
New +$3.66K
ROK icon
262
Rockwell Automation
ROK
$51.1B
$3K ﹤0.01%
20
-20
-50% -$3.34K
SLV icon
263
iShares Silver Trust
SLV
$27.7B
$3K ﹤0.01%
180
– –
CPB icon
264
Campbell Soup
CPB
$6.85B
$2K ﹤0.01%
72
– –
PFG icon
265
Principal Financial Group
PFG
$24.3B
$2K ﹤0.01%
50
– –
TWO
266
Two Harbors Investment
TWO
$1.27B
$2K ﹤0.01%
35
– –
ENB icon
267
Enbridge
ENB
$120B
$1K ﹤0.01%
+44
New +$1.42K
BBCA icon
268
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
– –
-135
Closed -$7K
BKNG icon
269
Booking.com
BKNG
$156B
– –
-8,925
Closed -$708K
CLX icon
270
Clorox
CLX
$12B
– –
-55
Closed -$8K
FTNT icon
271
Fortinet
FTNT
$112B
– –
-1,475
Closed -$27K
IEMG icon
272
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
– –
-137
Closed -$7K
ILMN icon
273
Illumina
ILMN
$29.5B
– –
-58
Closed -$21K
RCL icon
274
Royal Caribbean
RCL
$86.5B
– –
-2,942
Closed -$382K
YUM icon
275
Yum! Brands
YUM
$41.9B
– –
-233
Closed -$21K
8 9 10
11
12

Similar funds

JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $705M AUM 43.01% 1-Year Est. Return
GHCMRT
Graham Holdings Co Master Retirement Trust Arlington, Virginia $706M AUM 7.7% 1-Year Est. Return
IFM
ION Fund Management Herzliya $707M AUM
TWM
TRB Wealth Management Houston, Texas $704M AUM
SSCM
Summit Street Capital Management New York $707M AUM 76.8% 1-Year Est. Return
NG
Northstar Group New York $707M AUM 11.67% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $703M AUM 53.29% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Central Bank & Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Central Bank & Trust held 283 positions worth $396M, down 8.3% from $432M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Central Bank & Trust deployed $28.1M of net new capital in Q4 2018, opening 19 new positions and adding to 49 existing holdings. Its largest new stake was HP: 205,144 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Lam Research, an estimated $4.47M trimmed.

  • Central Bank & Trust's largest Q4 2018 buy was HP: 205,144 shares worth $4.2M.
  • Central Bank & Trust added most to Vanguard Emerging Markets Government Bond ETF in Q4 2018, an estimated $16.3M increase.
  • Central Bank & Trust's biggest Q4 2018 reduction was Lam Research, cutting an estimated $4.47M.
  • Central Bank & Trust fully exited Aetna Inc in Q4 2018, selling an estimated $2.43M.
  • Central Bank & Trust's ten largest holdings make up 35% of its $396M portfolio in Q4 2018.
  • Central Bank & Trust opened 19 new positions and closed 16 in Q4 2018.
  • Central Bank & Trust's portfolio value fell 8.3% quarter-over-quarter to $396M.

Based on Central Bank & Trust's 13F filing for Q4 2018, filed 17 Jan 2019.